New registry aims to unlock Long-Term data on prostate ablation

NCT ID NCT06705803

Recruiting now Knowledge-focused Sponsor: University of Chicago Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study creates a database to track men with prostate cancer who choose prostate ablation—a minimally invasive procedure to destroy cancer cells. Researchers will collect information from medical records on cancer control, side effects, and quality of life for up to 3,000 participants. The goal is to fill gaps in knowledge about how well ablation works over time, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could provide real-world evidence on how well prostate ablation works over the long term, helping doctors and patients make better treatment decisions.
What could go wrong: This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by differences in patient care and data completeness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

The University of Chicago
RECRUITING

Hyde Park, Illinois, 60637, United States
The University of Cinncinatti
RECRUITING

Cincinnati, Ohio, 45221, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.